Gene Symbol | Gene ID | Gene Info |
---|---|---|
WRNIP1
|
ENSG00000124535.11 | WRN helicase interacting protein 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_2761379_2761530 | WRNIP1 | 4194 | 0.231948 | -0.83 | 6.1e-03 | Click! |
chr6_2789704_2789855 | WRNIP1 | 20772 | 0.170567 | 0.79 | 1.2e-02 | Click! |
chr6_2767677_2767928 | WRNIP1 | 1205 | 0.494977 | -0.74 | 2.3e-02 | Click! |
chr6_2768502_2768745 | WRNIP1 | 384 | 0.869121 | -0.74 | 2.4e-02 | Click! |
chr6_2766579_2767037 | WRNIP1 | 522 | 0.797100 | -0.72 | 3.0e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr19_7989733_7990535 | 2.18 |
CTD-3193O13.8 |
|
752 |
0.29 |
chr9_94579747_94580327 | 2.17 |
ROR2 |
receptor tyrosine kinase-like orphan receptor 2 |
131125 |
0.05 |
chr8_49341467_49342503 | 2.11 |
ENSG00000252710 |
. |
121395 |
0.06 |
chr14_24837858_24838637 | 1.82 |
NFATC4 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 |
41 |
0.94 |
chr19_13133727_13134698 | 1.82 |
NFIX |
nuclear factor I/X (CCAAT-binding transcription factor) |
593 |
0.58 |
chr2_10417901_10418493 | 1.82 |
ENSG00000264030 |
. |
2560 |
0.25 |
chr17_36607297_36607925 | 1.81 |
ENSG00000260833 |
. |
321 |
0.87 |
chr17_38500621_38501691 | 1.75 |
RARA |
retinoic acid receptor, alpha |
337 |
0.77 |
chr21_47714776_47715544 | 1.75 |
YBEY |
ybeY metallopeptidase (putative) |
8601 |
0.11 |
chr22_36828593_36829238 | 1.74 |
ENSG00000252575 |
. |
6056 |
0.16 |
chr2_10425893_10426393 | 1.68 |
ENSG00000264030 |
. |
5386 |
0.18 |
chr17_76296960_76297664 | 1.68 |
SOCS3 |
suppressor of cytokine signaling 3 |
58843 |
0.08 |
chr19_58907233_58907815 | 1.66 |
AC012313.1 |
uncharacterized protein LOC646862 |
67 |
0.92 |
chr1_234858071_234858911 | 1.66 |
IRF2BP2 |
interferon regulatory factor 2 binding protein 2 |
113220 |
0.06 |
chr14_23549622_23550020 | 1.65 |
ACIN1 |
apoptotic chromatin condensation inducer 1 |
8995 |
0.09 |
chr19_709223_709862 | 1.65 |
PALM |
paralemmin |
441 |
0.7 |
chr7_92645118_92645650 | 1.61 |
ENSG00000266794 |
. |
44771 |
0.17 |
chr5_149852184_149852596 | 1.59 |
NDST1 |
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 |
12991 |
0.17 |
chr16_85596439_85597190 | 1.59 |
GSE1 |
Gse1 coiled-coil protein |
48201 |
0.14 |
chr7_73868587_73869056 | 1.58 |
GTF2IRD1 |
GTF2I repeat domain containing 1 |
382 |
0.88 |
chr4_113437546_113438608 | 1.56 |
NEUROG2 |
neurogenin 2 |
749 |
0.58 |
chr16_75278250_75278858 | 1.55 |
BCAR1 |
breast cancer anti-estrogen resistance 1 |
1954 |
0.25 |
chr22_38614803_38615828 | 1.50 |
MAFF |
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F |
5773 |
0.12 |
chr11_73024899_73025487 | 1.49 |
ARHGEF17 |
Rho guanine nucleotide exchange factor (GEF) 17 |
2583 |
0.2 |
chr3_45589006_45589723 | 1.49 |
LARS2-AS1 |
LARS2 antisense RNA 1 |
38327 |
0.14 |
chr6_35393359_35394053 | 1.46 |
FANCE |
Fanconi anemia, complementation group E |
26432 |
0.15 |
chr19_42626039_42626662 | 1.46 |
POU2F2 |
POU class 2 homeobox 2 |
382 |
0.74 |
chr19_50284218_50285014 | 1.42 |
AP2A1 |
adaptor-related protein complex 2, alpha 1 subunit |
14225 |
0.07 |
chr9_130601372_130601801 | 1.39 |
ENSG00000222455 |
. |
1915 |
0.15 |
chr10_134224918_134226015 | 1.38 |
PWWP2B |
PWWP domain containing 2B |
14764 |
0.17 |
chr11_118791485_118792723 | 1.37 |
BCL9L |
B-cell CLL/lymphoma 9-like |
2491 |
0.13 |
chr12_6657819_6658220 | 1.36 |
IFFO1 |
intermediate filament family orphan 1 |
3047 |
0.1 |
chr3_122803125_122803484 | 1.35 |
PDIA5 |
protein disulfide isomerase family A, member 5 |
17109 |
0.23 |
chr1_220863452_220864325 | 1.35 |
C1orf115 |
chromosome 1 open reading frame 115 |
701 |
0.71 |
chr12_48170736_48171336 | 1.33 |
SLC48A1 |
solute carrier family 48 (heme transporter), member 1 |
4045 |
0.16 |
chr11_118789955_118791011 | 1.33 |
BCL9L |
B-cell CLL/lymphoma 9-like |
870 |
0.37 |
chr1_22259868_22260816 | 1.30 |
HSPG2 |
heparan sulfate proteoglycan 2 |
3448 |
0.18 |
chr17_56031434_56032135 | 1.29 |
CUEDC1 |
CUE domain containing 1 |
834 |
0.58 |
chr12_57542255_57543089 | 1.28 |
RP11-545N8.3 |
|
1270 |
0.29 |
chr1_3231005_3231304 | 1.26 |
PRDM16 |
PR domain containing 16 |
70458 |
0.11 |
chr5_394336_394571 | 1.24 |
AHRR |
aryl-hydrocarbon receptor repressor |
26582 |
0.14 |
chr9_136821628_136822276 | 1.24 |
VAV2 |
vav 2 guanine nucleotide exchange factor |
35451 |
0.17 |
chr1_44705174_44705804 | 1.24 |
ERI3-IT1 |
ERI3 intronic transcript 1 (non-protein coding) |
4456 |
0.21 |
chr1_17305422_17305972 | 1.23 |
RP1-37C10.3 |
|
276 |
0.81 |
chr9_137661433_137661732 | 1.23 |
COL5A1 |
collagen, type V, alpha 1 |
54908 |
0.07 |
chr19_8017646_8018209 | 1.22 |
CTD-3193O13.14 |
|
6080 |
0.08 |
chr17_79070617_79071314 | 1.22 |
BAIAP2 |
BAI1-associated protein 2 |
414 |
0.74 |
chr7_2672947_2673687 | 1.21 |
TTYH3 |
tweety family member 3 |
1527 |
0.39 |
chr16_4378324_4378965 | 1.20 |
GLIS2 |
GLIS family zinc finger 2 |
3581 |
0.16 |
chr14_25518403_25519489 | 1.19 |
STXBP6 |
syntaxin binding protein 6 (amisyn) |
149 |
0.98 |
chr2_42795325_42795726 | 1.18 |
MTA3 |
metastasis associated 1 family, member 3 |
132 |
0.97 |
chr11_65257627_65258285 | 1.17 |
SCYL1 |
SCY1-like 1 (S. cerevisiae) |
34592 |
0.08 |
chr17_55970745_55971087 | 1.17 |
CUEDC1 |
CUE domain containing 1 |
867 |
0.58 |
chr9_69786015_69786709 | 1.16 |
IGKV1OR-2 |
immunoglobulin kappa variable 1/OR-2 (pseudogene) |
8409 |
0.25 |
chr3_50195246_50195978 | 1.16 |
SEMA3F |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
840 |
0.45 |
chr8_140716343_140716851 | 1.15 |
KCNK9 |
potassium channel, subfamily K, member 9 |
1298 |
0.63 |
chr3_183947384_183948074 | 1.14 |
VWA5B2 |
von Willebrand factor A domain containing 5B2 |
488 |
0.65 |
chr10_118999887_119000484 | 1.14 |
SLC18A2 |
solute carrier family 18 (vesicular monoamine transporter), member 2 |
419 |
0.76 |
chr19_13120371_13120965 | 1.14 |
NFIX |
nuclear factor I/X (CCAAT-binding transcription factor) |
2334 |
0.15 |
chr1_153572031_153572387 | 1.14 |
S100A16 |
S100 calcium binding protein A16 |
8589 |
0.08 |
chr19_46284301_46284684 | 1.14 |
DMPK |
dystrophia myotonica-protein kinase |
487 |
0.59 |
chr10_134235252_134235583 | 1.13 |
RP11-432J24.3 |
|
19571 |
0.16 |
chr11_65343918_65345038 | 1.13 |
EHBP1L1 |
EH domain binding protein 1-like 1 |
961 |
0.3 |
chr1_156675699_156676565 | 1.13 |
CRABP2 |
cellular retinoic acid binding protein 2 |
524 |
0.6 |
chr12_53445964_53446394 | 1.11 |
RP11-983P16.4 |
|
1989 |
0.19 |
chr1_161187267_161187955 | 1.11 |
FCER1G |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
2524 |
0.1 |
chr6_108881149_108881832 | 1.10 |
FOXO3 |
forkhead box O3 |
452 |
0.89 |
chr17_56159992_56160555 | 1.10 |
DYNLL2 |
dynein, light chain, LC8-type 2 |
503 |
0.79 |
chr11_64099436_64100161 | 1.10 |
AP003774.1 |
|
2822 |
0.1 |
chr15_101711256_101711683 | 1.09 |
CHSY1 |
chondroitin sulfate synthase 1 |
80668 |
0.08 |
chr9_35563827_35564325 | 1.08 |
FAM166B |
family with sequence similarity 166, member B |
180 |
0.92 |
chr19_47524229_47524951 | 1.08 |
NPAS1 |
neuronal PAS domain protein 1 |
447 |
0.8 |
chr9_130597546_130598271 | 1.08 |
ENSG00000222296 |
. |
1587 |
0.18 |
chr19_16176364_16176713 | 1.08 |
TPM4 |
tropomyosin 4 |
1293 |
0.44 |
chr3_50204088_50204384 | 1.08 |
ENSG00000207922 |
. |
6523 |
0.12 |
chr17_38692508_38692959 | 1.07 |
CCR7 |
chemokine (C-C motif) receptor 7 |
24532 |
0.14 |
chr1_6301763_6302398 | 1.07 |
HES3 |
hes family bHLH transcription factor 3 |
2172 |
0.18 |
chr13_114831463_114832357 | 1.07 |
RASA3 |
RAS p21 protein activator 3 |
11528 |
0.24 |
chr19_30334052_30334510 | 1.06 |
CCNE1 |
cyclin E1 |
26171 |
0.23 |
chr12_63122687_63123266 | 1.06 |
ENSG00000238475 |
. |
78021 |
0.09 |
chr16_85403825_85404233 | 1.06 |
RP11-680G10.1 |
Uncharacterized protein |
12960 |
0.23 |
chr10_104387858_104388403 | 1.05 |
TRIM8 |
tripartite motif containing 8 |
16123 |
0.16 |
chr11_19221880_19222197 | 1.05 |
CSRP3 |
cysteine and glycine-rich protein 3 (cardiac LIM protein) |
1551 |
0.37 |
chr12_68953819_68954333 | 1.05 |
RAP1B |
RAP1B, member of RAS oncogene family |
50543 |
0.15 |
chr9_130615331_130616090 | 1.05 |
ENG |
endoglin |
1205 |
0.25 |
chr6_16801385_16801811 | 1.05 |
RP1-151F17.1 |
|
39455 |
0.18 |
chr16_69120841_69121192 | 1.05 |
HAS3 |
hyaluronan synthase 3 |
18451 |
0.15 |
chr12_57487197_57487835 | 1.05 |
NAB2 |
NGFI-A binding protein 2 (EGR1 binding protein 2) |
4626 |
0.11 |
chr9_107826117_107826807 | 1.04 |
ENSG00000201583 |
. |
32575 |
0.22 |
chr11_60906509_60907112 | 1.03 |
VPS37C |
vacuolar protein sorting 37 homolog C (S. cerevisiae) |
21798 |
0.14 |
chr14_23316976_23317711 | 1.03 |
ENSG00000212335 |
. |
4594 |
0.09 |
chr11_36035998_36036518 | 1.03 |
ENSG00000263389 |
. |
4610 |
0.26 |
chr8_99438628_99439079 | 1.03 |
KCNS2 |
potassium voltage-gated channel, delayed-rectifier, subfamily S, member 2 |
397 |
0.86 |
chr13_114563717_114564199 | 1.02 |
GAS6 |
growth arrest-specific 6 |
3082 |
0.32 |
chr1_9750618_9751880 | 1.02 |
RP11-558F24.4 |
|
3636 |
0.21 |
chr8_49565421_49565933 | 1.02 |
EFCAB1 |
EF-hand calcium binding domain 1 |
76671 |
0.11 |
chr11_67141426_67142374 | 1.01 |
CLCF1 |
cardiotrophin-like cytokine factor 1 |
252 |
0.81 |
chr5_139039554_139039936 | 1.01 |
CXXC5 |
CXXC finger protein 5 |
605 |
0.77 |
chr13_24191415_24191876 | 1.00 |
TNFRSF19 |
tumor necrosis factor receptor superfamily, member 19 |
38126 |
0.2 |
chr3_12228814_12229439 | 1.00 |
TIMP4 |
TIMP metallopeptidase inhibitor 4 |
28275 |
0.22 |
chr11_67779955_67780302 | 1.00 |
ALDH3B1 |
aldehyde dehydrogenase 3 family, member B1 |
2338 |
0.17 |
chr5_177904947_177905202 | 1.00 |
CTB-26E19.1 |
|
34979 |
0.17 |
chr1_150244620_150245106 | 1.00 |
C1orf54 |
chromosome 1 open reading frame 54 |
239 |
0.83 |
chr19_11253483_11254153 | 1.00 |
SPC24 |
SPC24, NDC80 kinetochore complex component |
12619 |
0.13 |
chr9_38038631_38039019 | 1.00 |
SHB |
Src homology 2 domain containing adaptor protein B |
30383 |
0.2 |
chr16_89258494_89259013 | 1.00 |
SLC22A31 |
solute carrier family 22, member 31 |
9319 |
0.12 |
chr19_35630229_35630677 | 0.99 |
FXYD1 |
FXYD domain containing ion transport regulator 1 |
108 |
0.92 |
chr14_103986978_103987655 | 0.99 |
CKB |
creatine kinase, brain |
122 |
0.92 |
chr17_75471369_75472155 | 0.98 |
SEPT9 |
septin 9 |
437 |
0.78 |
chr1_155223556_155224415 | 0.97 |
FAM189B |
family with sequence similarity 189, member B |
714 |
0.38 |
chr19_3374839_3375060 | 0.97 |
NFIC |
nuclear factor I/C (CCAAT-binding transcription factor) |
8365 |
0.19 |
chr1_230849583_230849871 | 0.97 |
AGT |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
316 |
0.87 |
chr1_110778111_110778442 | 0.97 |
KCNC4 |
potassium voltage-gated channel, Shaw-related subfamily, member 4 |
24154 |
0.12 |
chr22_46933945_46934657 | 0.96 |
CELSR1 |
cadherin, EGF LAG seven-pass G-type receptor 1 |
1234 |
0.46 |
chr17_36862672_36863533 | 0.96 |
CTB-58E17.3 |
|
588 |
0.44 |
chr12_116819821_116820288 | 0.96 |
ENSG00000264037 |
. |
46069 |
0.17 |
chr9_132096828_132097338 | 0.96 |
ENSG00000242281 |
. |
35657 |
0.16 |
chr16_85429807_85430115 | 0.96 |
RP11-680G10.1 |
Uncharacterized protein |
38892 |
0.16 |
chr6_3457336_3457772 | 0.95 |
SLC22A23 |
solute carrier family 22, member 23 |
298 |
0.94 |
chr22_45124444_45125024 | 0.94 |
PRR5 |
proline rich 5 (renal) |
1950 |
0.33 |
chr12_132111377_132111841 | 0.94 |
ENSG00000212154 |
. |
33999 |
0.2 |
chr2_74755282_74756348 | 0.94 |
HTRA2 |
HtrA serine peptidase 2 |
689 |
0.35 |
chr12_52579893_52580044 | 0.94 |
KRT80 |
keratin 80 |
5816 |
0.14 |
chr10_80897727_80898445 | 0.94 |
ZMIZ1 |
zinc finger, MIZ-type containing 1 |
69294 |
0.12 |
chr17_77715532_77716324 | 0.94 |
ENPP7 |
ectonucleotide pyrophosphatase/phosphodiesterase 7 |
6588 |
0.15 |
chr5_394621_394832 | 0.93 |
AHRR |
aryl-hydrocarbon receptor repressor |
26309 |
0.14 |
chr10_77043270_77043638 | 0.93 |
COMTD1 |
catechol-O-methyltransferase domain containing 1 |
47685 |
0.14 |
chr2_119981918_119982387 | 0.93 |
STEAP3 |
STEAP family member 3, metalloreductase |
723 |
0.69 |
chr17_71319929_71320201 | 0.93 |
CDC42EP4 |
CDC42 effector protein (Rho GTPase binding) 4 |
11751 |
0.2 |
chr6_44044467_44044818 | 0.92 |
RP5-1120P11.1 |
|
2253 |
0.28 |
chr19_1513130_1513873 | 0.92 |
ADAMTSL5 |
ADAMTS-like 5 |
313 |
0.73 |
chr7_157405725_157406364 | 0.92 |
AC005481.5 |
Uncharacterized protein |
671 |
0.75 |
chr11_1146453_1147024 | 0.92 |
MUC5AC |
mucin 5AC, oligomeric mucus/gel-forming |
4842 |
0.22 |
chr15_101741938_101742937 | 0.92 |
CHSY1 |
chondroitin sulfate synthase 1 |
49700 |
0.12 |
chr10_104436480_104437015 | 0.92 |
TRIM8 |
tripartite motif containing 8 |
32103 |
0.12 |
chr3_122803672_122804475 | 0.92 |
PDIA5 |
protein disulfide isomerase family A, member 5 |
17878 |
0.23 |
chr22_39648907_39649454 | 0.92 |
AL031590.1 |
|
7883 |
0.14 |
chr19_41196829_41197444 | 0.92 |
NUMBL |
numb homolog (Drosophila)-like |
259 |
0.87 |
chr19_14049210_14049672 | 0.91 |
PODNL1 |
podocan-like 1 |
152 |
0.91 |
chr16_53086693_53086853 | 0.91 |
RP11-467J12.4 |
|
12 |
0.98 |
chr6_35457763_35458156 | 0.91 |
TEAD3 |
TEA domain family member 3 |
6768 |
0.17 |
chr7_73304783_73305010 | 0.91 |
WBSCR28 |
Williams-Beuren syndrome chromosome region 28 |
29407 |
0.15 |
chr12_4140465_4141124 | 0.91 |
RP11-664D1.1 |
|
126408 |
0.05 |
chr22_22291490_22292290 | 0.91 |
LL22NC03-86G7.1 |
|
719 |
0.44 |
chr17_36667174_36667728 | 0.91 |
ARHGAP23 |
Rho GTPase activating protein 23 |
13416 |
0.16 |
chr16_29093393_29093944 | 0.90 |
RRN3P2 |
RNA polymerase I transcription factor homolog (S. cerevisiae) pseudogene 2 |
7325 |
0.13 |
chr22_30604075_30604921 | 0.90 |
RP3-438O4.4 |
|
1400 |
0.33 |
chr4_23946972_23947800 | 0.90 |
PPARGC1A |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
55686 |
0.17 |
chr3_115418257_115418556 | 0.90 |
RP11-326J18.1 |
|
41026 |
0.2 |
chr16_16168105_16168644 | 0.90 |
ABCC1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
64661 |
0.11 |
chr5_148801935_148802347 | 0.89 |
ENSG00000208035 |
. |
6340 |
0.15 |
chr11_61690283_61690510 | 0.89 |
RAB3IL1 |
RAB3A interacting protein (rabin3)-like 1 |
2655 |
0.18 |
chr10_120788305_120788993 | 0.89 |
NANOS1 |
nanos homolog 1 (Drosophila) |
579 |
0.67 |
chr11_12088585_12089097 | 0.89 |
MICAL2 |
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
26702 |
0.22 |
chr22_37914494_37915327 | 0.89 |
CARD10 |
caspase recruitment domain family, member 10 |
337 |
0.83 |
chr19_36360617_36361346 | 0.89 |
APLP1 |
amyloid beta (A4) precursor-like protein 1 |
105 |
0.92 |
chr17_48766733_48767153 | 0.88 |
RP11-294J22.6 |
|
3866 |
0.14 |
chr19_42781870_42782547 | 0.88 |
CIC |
capicua transcriptional repressor |
5964 |
0.09 |
chr14_101159868_101160141 | 0.88 |
DLK1 |
delta-like 1 homolog (Drosophila) |
32038 |
0.1 |
chr5_76925321_76925875 | 0.88 |
WDR41 |
WD repeat domain 41 |
9162 |
0.23 |
chr1_225952011_225952404 | 0.88 |
SRP9 |
signal recognition particle 9kDa |
13324 |
0.14 |
chr18_43381728_43382214 | 0.88 |
SIGLEC15 |
sialic acid binding Ig-like lectin 15 |
23506 |
0.18 |
chr1_112276693_112276998 | 0.88 |
FAM212B |
family with sequence similarity 212, member B |
5030 |
0.18 |
chr8_11871702_11872239 | 0.88 |
RP11-481A20.11 |
Protein LOC101060662 |
1073 |
0.43 |
chr19_42592250_42592591 | 0.88 |
POU2F2 |
POU class 2 homeobox 2 |
7137 |
0.11 |
chr2_65772818_65773170 | 0.87 |
ENSG00000243029 |
. |
164 |
0.96 |
chr17_36604180_36604649 | 0.87 |
ENSG00000260833 |
. |
3518 |
0.2 |
chr6_44026555_44026902 | 0.87 |
RP5-1120P11.1 |
|
15661 |
0.16 |
chr17_74525558_74526004 | 0.87 |
CYGB |
cytoglobin |
2366 |
0.14 |
chr17_66374516_66374972 | 0.87 |
ENSG00000207561 |
. |
45945 |
0.13 |
chr18_77722000_77722505 | 0.87 |
HSBP1L1 |
heat shock factor binding protein 1-like 1 |
2309 |
0.28 |
chr19_55998538_55999092 | 0.87 |
SSC5D |
scavenger receptor cysteine rich domain containing (5 domains) |
956 |
0.27 |
chr10_112152381_112152679 | 0.87 |
ENSG00000221359 |
. |
41469 |
0.15 |
chr1_95200451_95201012 | 0.87 |
ENSG00000263526 |
. |
10725 |
0.26 |
chr11_124587564_124588604 | 0.87 |
NRGN |
neurogranin (protein kinase C substrate, RC3) |
21658 |
0.09 |
chr5_133842003_133842294 | 0.86 |
ENSG00000207222 |
. |
6173 |
0.17 |
chr17_4848069_4849234 | 0.86 |
PFN1 |
profilin 1 |
2113 |
0.1 |
chr15_67066192_67066777 | 0.86 |
SMAD6 |
SMAD family member 6 |
62449 |
0.13 |
chr10_99478408_99478800 | 0.86 |
MARVELD1 |
MARVEL domain containing 1 |
5123 |
0.17 |
chr1_75139191_75139830 | 0.86 |
C1orf173 |
chromosome 1 open reading frame 173 |
88 |
0.98 |
chr3_50279084_50280004 | 0.86 |
GNAI2 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
4000 |
0.12 |
chr1_15479528_15480070 | 0.86 |
TMEM51 |
transmembrane protein 51 |
430 |
0.86 |
chr2_74732516_74733402 | 0.85 |
LBX2 |
ladybird homeobox 2 |
2516 |
0.09 |
chr16_29821466_29822127 | 0.85 |
AC009133.14 |
|
768 |
0.3 |
chr10_133999367_134000256 | 0.85 |
RP11-140A10.3 |
|
345 |
0.67 |
chr12_124864748_124865018 | 0.85 |
NCOR2 |
nuclear receptor corepressor 2 |
8487 |
0.28 |
chr19_45995891_45996348 | 0.85 |
RTN2 |
reticulon 2 |
406 |
0.74 |
chr20_43921459_43922264 | 0.85 |
MATN4 |
matrilin 4 |
12370 |
0.12 |
chr17_7746157_7747127 | 0.85 |
KDM6B |
lysine (K)-specific demethylase 6B |
1591 |
0.22 |
chr6_393086_393625 | 0.85 |
IRF4 |
interferon regulatory factor 4 |
1616 |
0.51 |
chr16_57835025_57835353 | 0.85 |
KIFC3 |
kinesin family member C3 |
1172 |
0.4 |
chr10_328679_329000 | 0.84 |
ENSG00000201861 |
. |
774 |
0.65 |
chr5_148831707_148832136 | 0.84 |
ENSG00000269936 |
. |
21712 |
0.13 |
chr22_51016890_51017529 | 0.84 |
CPT1B |
carnitine palmitoyltransferase 1B (muscle) |
113 |
0.91 |
chr12_2397196_2397863 | 0.84 |
CACNA1C-IT3 |
CACNA1C intronic transcript 3 (non-protein coding) |
18587 |
0.24 |
chr8_22455593_22456026 | 0.84 |
C8orf58 |
chromosome 8 open reading frame 58 |
1305 |
0.26 |
chr16_70462214_70463164 | 0.84 |
ST3GAL2 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 2 |
10302 |
0.12 |
chr5_175299080_175299718 | 0.83 |
CPLX2 |
complexin 2 |
414 |
0.87 |
chr19_45221957_45222192 | 0.83 |
CTB-171A8.1 |
|
43 |
0.96 |
chr1_234856307_234857026 | 0.83 |
IRF2BP2 |
interferon regulatory factor 2 binding protein 2 |
111395 |
0.06 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.7 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.8 | 0.8 | GO:0060433 | bronchus development(GO:0060433) |
0.8 | 3.2 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.7 | 3.0 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.7 | 1.4 | GO:0010193 | response to ozone(GO:0010193) |
0.7 | 2.1 | GO:0035581 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.7 | 2.0 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.6 | 3.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.6 | 1.9 | GO:0021508 | floor plate formation(GO:0021508) |
0.6 | 1.7 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.5 | 3.5 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.5 | 1.5 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.5 | 1.4 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.5 | 2.8 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.5 | 1.8 | GO:0009169 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.5 | 0.5 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.4 | 1.3 | GO:0003078 | obsolete regulation of natriuresis(GO:0003078) |
0.4 | 1.3 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
0.4 | 1.3 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.4 | 1.7 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.4 | 1.2 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.4 | 1.2 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.4 | 2.8 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.4 | 0.8 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.4 | 0.8 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.4 | 1.9 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.4 | 1.9 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.4 | 1.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.4 | 1.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.4 | 1.1 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.4 | 1.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.4 | 1.1 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
0.4 | 1.4 | GO:0018101 | protein citrullination(GO:0018101) |
0.4 | 0.7 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.3 | 0.7 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.3 | 1.7 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.3 | 0.3 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.3 | 1.3 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.3 | 1.0 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.3 | 1.0 | GO:0019049 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.3 | 1.0 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.3 | 1.0 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.3 | 1.3 | GO:0051014 | actin filament severing(GO:0051014) |
0.3 | 2.7 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.3 | 0.3 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.3 | 0.3 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.3 | 0.6 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
0.3 | 0.9 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.3 | 1.5 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) |
0.3 | 2.0 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.3 | 0.6 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.3 | 0.3 | GO:0032288 | myelin assembly(GO:0032288) |
0.3 | 1.4 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.3 | 0.3 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.3 | 0.8 | GO:0044320 | cellular response to leptin stimulus(GO:0044320) response to leptin(GO:0044321) |
0.3 | 1.1 | GO:0014034 | neural crest formation(GO:0014029) neural crest cell fate commitment(GO:0014034) |
0.3 | 1.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.3 | 0.6 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.3 | 2.2 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.3 | 0.8 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.3 | 0.3 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.3 | 0.5 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.3 | 0.5 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.3 | 0.8 | GO:0001878 | response to yeast(GO:0001878) |
0.3 | 0.3 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.3 | 1.0 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.3 | 0.5 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.3 | 0.5 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.2 | 0.2 | GO:0032261 | purine nucleotide salvage(GO:0032261) |
0.2 | 0.7 | GO:0060426 | lung vasculature development(GO:0060426) |
0.2 | 0.5 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.2 | 3.6 | GO:0002040 | sprouting angiogenesis(GO:0002040) |
0.2 | 0.2 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.2 | 0.2 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.2 | 0.7 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.2 | 1.3 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
0.2 | 0.2 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.2 | 0.2 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.2 | 1.1 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.2 | 0.9 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 0.9 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.2 | 0.2 | GO:0061043 | vascular wound healing(GO:0061042) regulation of vascular wound healing(GO:0061043) |
0.2 | 0.6 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 0.6 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.2 | 0.6 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.2 | 1.3 | GO:0090504 | wound healing, spreading of epidermal cells(GO:0035313) wound healing, spreading of cells(GO:0044319) epiboly(GO:0090504) epiboly involved in wound healing(GO:0090505) |
0.2 | 1.0 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.2 | 1.3 | GO:1901655 | cellular response to ketone(GO:1901655) |
0.2 | 0.8 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.2 | 0.2 | GO:0070254 | mucus secretion(GO:0070254) |
0.2 | 0.6 | GO:0010842 | retina layer formation(GO:0010842) |
0.2 | 0.4 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.2 | 0.4 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
0.2 | 1.0 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.2 | 0.2 | GO:0003170 | heart valve development(GO:0003170) heart valve morphogenesis(GO:0003179) |
0.2 | 0.8 | GO:0035307 | positive regulation of dephosphorylation(GO:0035306) positive regulation of protein dephosphorylation(GO:0035307) |
0.2 | 3.4 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.2 | 0.2 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) |
0.2 | 0.6 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.2 | 0.8 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.2 | 0.9 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.2 | 1.1 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.2 | 0.7 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.2 | 0.6 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.2 | 1.7 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.2 | 0.4 | GO:0060753 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.2 | 1.1 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.2 | 0.4 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.2 | 0.7 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.2 | 0.9 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.2 | 1.1 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.2 | 0.7 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.2 | 0.2 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.2 | 0.5 | GO:2000178 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) |
0.2 | 1.8 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.2 | 0.9 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.2 | 0.7 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.2 | 0.5 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.2 | 0.2 | GO:1904063 | negative regulation of calcium ion import(GO:0090281) negative regulation of cation transmembrane transport(GO:1904063) |
0.2 | 1.4 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 0.7 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.2 | 0.5 | GO:0032898 | neurotrophin production(GO:0032898) |
0.2 | 0.2 | GO:0033622 | integrin activation(GO:0033622) |
0.2 | 0.2 | GO:0060439 | trachea morphogenesis(GO:0060439) |
0.2 | 0.2 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.2 | 0.8 | GO:0008228 | opsonization(GO:0008228) |
0.2 | 0.5 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.2 | 0.5 | GO:0009415 | response to water deprivation(GO:0009414) response to water(GO:0009415) |
0.2 | 0.8 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.2 | 0.6 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.2 | 0.3 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.2 | 0.6 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.2 | 0.3 | GO:0045924 | regulation of female receptivity(GO:0045924) female mating behavior(GO:0060180) |
0.2 | 0.9 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.2 | 0.6 | GO:0032329 | serine transport(GO:0032329) |
0.2 | 0.9 | GO:1901532 | regulation of megakaryocyte differentiation(GO:0045652) regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.2 | 0.3 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.2 | 1.2 | GO:0009629 | response to gravity(GO:0009629) |
0.2 | 0.2 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.2 | 1.2 | GO:0006853 | carnitine shuttle(GO:0006853) carnitine transmembrane transport(GO:1902603) |
0.2 | 1.2 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.4 | GO:1902803 | regulation of synaptic vesicle transport(GO:1902803) regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 | 0.9 | GO:0010225 | response to UV-C(GO:0010225) |
0.1 | 1.8 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 0.1 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 0.4 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.1 | 0.1 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.1 | 0.6 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 0.4 | GO:0007132 | meiotic metaphase I(GO:0007132) |
0.1 | 0.1 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.1 | 0.6 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.1 | 0.4 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.4 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.6 | GO:0002686 | negative regulation of leukocyte migration(GO:0002686) |
0.1 | 1.1 | GO:0048844 | artery morphogenesis(GO:0048844) |
0.1 | 0.3 | GO:0001845 | phagolysosome assembly(GO:0001845) phagosome maturation(GO:0090382) |
0.1 | 0.5 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.1 | 0.9 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.1 | 0.5 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.1 | 0.5 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.1 | 0.3 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.1 | 0.8 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 0.5 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.5 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.5 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.1 | 0.3 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.1 | 0.3 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.5 | GO:1902624 | positive regulation of neutrophil chemotaxis(GO:0090023) positive regulation of neutrophil migration(GO:1902624) |
0.1 | 0.4 | GO:0000470 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
0.1 | 0.6 | GO:0031641 | regulation of myelination(GO:0031641) |
0.1 | 0.9 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.5 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 2.8 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.1 | 0.6 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.1 | 0.6 | GO:0016265 | obsolete death(GO:0016265) |
0.1 | 0.4 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 0.2 | GO:0042748 | circadian sleep/wake cycle, non-REM sleep(GO:0042748) regulation of circadian sleep/wake cycle, non-REM sleep(GO:0045188) |
0.1 | 0.6 | GO:0015824 | proline transport(GO:0015824) |
0.1 | 0.7 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.2 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.1 | 0.2 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.1 | 0.7 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.1 | 0.3 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.1 | 0.1 | GO:0045713 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) |
0.1 | 0.2 | GO:1902692 | positive regulation of neuroblast proliferation(GO:0002052) regulation of neuroblast proliferation(GO:1902692) |
0.1 | 0.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 0.4 | GO:0007494 | midgut development(GO:0007494) |
0.1 | 0.2 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.1 | 0.1 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 0.5 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.1 | 0.3 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.1 | 0.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.3 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.1 | 0.2 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.1 | 0.4 | GO:0060174 | limb bud formation(GO:0060174) |
0.1 | 0.3 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.2 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.3 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 0.5 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.2 | GO:0046021 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.1 | 0.8 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.1 | 0.2 | GO:0060039 | pericardium development(GO:0060039) |
0.1 | 1.2 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.1 | 0.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.2 | GO:0043084 | penile erection(GO:0043084) |
0.1 | 0.2 | GO:0070572 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.1 | 0.8 | GO:0045176 | apical protein localization(GO:0045176) |
0.1 | 0.2 | GO:0045425 | positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) |
0.1 | 0.3 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
0.1 | 0.4 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 1.4 | GO:0042762 | regulation of sulfur metabolic process(GO:0042762) |
0.1 | 0.5 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.2 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 0.1 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.1 | 0.3 | GO:0060298 | regulation of sarcomere organization(GO:0060297) positive regulation of sarcomere organization(GO:0060298) |
0.1 | 0.8 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.4 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.1 | 0.3 | GO:0048245 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.1 | 0.2 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) |
0.1 | 0.4 | GO:0001885 | endothelial cell development(GO:0001885) |
0.1 | 0.3 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.1 | 0.2 | GO:1901798 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.1 | 0.3 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.1 | 0.2 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.1 | 0.3 | GO:0060013 | righting reflex(GO:0060013) |
0.1 | 0.2 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.1 | 0.2 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.1 | 0.1 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
0.1 | 0.1 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.1 | 0.2 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.1 | 0.4 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.3 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.1 | 0.6 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.5 | GO:0031269 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 0.4 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 0.1 | GO:0021938 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.1 | 0.3 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 0.2 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 0.4 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.1 | 0.2 | GO:2000846 | corticosteroid hormone secretion(GO:0035930) regulation of steroid hormone secretion(GO:2000831) regulation of corticosteroid hormone secretion(GO:2000846) |
0.1 | 0.2 | GO:0072179 | nephric duct formation(GO:0072179) |
0.1 | 0.3 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.1 | 0.3 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.1 | 1.4 | GO:0030815 | negative regulation of cAMP metabolic process(GO:0030815) negative regulation of cAMP biosynthetic process(GO:0030818) |
0.1 | 0.1 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
0.1 | 0.3 | GO:0016999 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.1 | 0.3 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.1 | 0.1 | GO:0060412 | ventricular septum morphogenesis(GO:0060412) |
0.1 | 0.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.3 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.1 | 0.4 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.1 | 0.6 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
0.1 | 0.2 | GO:0061117 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of cardiac muscle tissue development(GO:0055026) negative regulation of cardiac muscle cell proliferation(GO:0060044) negative regulation of heart growth(GO:0061117) |
0.1 | 0.1 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.1 | 0.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.2 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.1 | 0.3 | GO:0009750 | response to fructose(GO:0009750) |
0.1 | 0.8 | GO:0030501 | positive regulation of bone mineralization(GO:0030501) |
0.1 | 0.2 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 1.4 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.5 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.1 | 0.5 | GO:0021772 | olfactory bulb development(GO:0021772) |
0.1 | 0.5 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.1 | GO:0032641 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.1 | 0.2 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 1.0 | GO:0048286 | lung alveolus development(GO:0048286) |
0.1 | 0.1 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.1 | GO:0047496 | vesicle transport along microtubule(GO:0047496) vesicle cytoskeletal trafficking(GO:0099518) |
0.1 | 0.6 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 1.4 | GO:0006662 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.1 | 0.3 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.1 | 0.7 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.1 | GO:0002885 | positive regulation of hypersensitivity(GO:0002885) |
0.1 | 0.2 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.1 | 1.4 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.1 | 0.1 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.1 | 0.4 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.1 | 0.4 | GO:0060998 | regulation of dendritic spine development(GO:0060998) |
0.1 | 0.9 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.3 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 1.4 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.3 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.3 | GO:0016246 | RNA interference(GO:0016246) |
0.1 | 0.1 | GO:0060004 | reflex(GO:0060004) |
0.1 | 0.1 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.1 | 0.3 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.4 | GO:0009200 | deoxyribonucleoside triphosphate metabolic process(GO:0009200) |
0.1 | 0.1 | GO:0019511 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.2 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.3 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
0.1 | 0.1 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
0.1 | 0.1 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
0.1 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.2 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 0.5 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.1 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.1 | 0.2 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.1 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.1 | 0.2 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.1 | 0.1 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.1 | GO:0003161 | cardiac conduction system development(GO:0003161) |
0.1 | 0.1 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.1 | 0.2 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 0.3 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.1 | 0.1 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 0.1 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.1 | 0.2 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 0.7 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.1 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 0.5 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.1 | 0.1 | GO:0046886 | positive regulation of hormone metabolic process(GO:0032352) positive regulation of hormone biosynthetic process(GO:0046886) |
0.1 | 0.3 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.1 | 0.1 | GO:0032277 | regulation of gonadotropin secretion(GO:0032276) negative regulation of gonadotropin secretion(GO:0032277) |
0.1 | 0.2 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.1 | 0.2 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.1 | 0.2 | GO:0048596 | embryonic camera-type eye morphogenesis(GO:0048596) |
0.1 | 0.3 | GO:0015858 | nucleoside transport(GO:0015858) |
0.1 | 0.8 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.2 | GO:0048854 | brain morphogenesis(GO:0048854) |
0.1 | 0.1 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.1 | 0.3 | GO:0046541 | saliva secretion(GO:0046541) |
0.1 | 0.2 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.1 | 0.2 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.1 | GO:0010560 | positive regulation of glycoprotein biosynthetic process(GO:0010560) positive regulation of glycoprotein metabolic process(GO:1903020) |
0.1 | 0.2 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.1 | 0.1 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.4 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.1 | 0.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.7 | GO:0006825 | copper ion transport(GO:0006825) |
0.1 | 0.2 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 0.1 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 0.3 | GO:0015840 | urea transport(GO:0015840) |
0.1 | 0.1 | GO:0060457 | negative regulation of digestive system process(GO:0060457) |
0.1 | 0.3 | GO:0050746 | regulation of lipoprotein metabolic process(GO:0050746) |
0.1 | 0.2 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.1 | 0.2 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 1.1 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.2 | GO:0001738 | morphogenesis of a polarized epithelium(GO:0001738) |
0.0 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.1 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.0 | 0.2 | GO:0002478 | antigen processing and presentation of exogenous peptide antigen(GO:0002478) |
0.0 | 0.8 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 0.0 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.0 | 0.4 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.1 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.0 | 0.2 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.6 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.3 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.0 | 1.1 | GO:0007588 | excretion(GO:0007588) |
0.0 | 0.0 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.0 | 0.2 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 0.1 | GO:1903312 | negative regulation of mRNA processing(GO:0050686) negative regulation of mRNA metabolic process(GO:1903312) |
0.0 | 0.6 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.0 | GO:0014052 | gamma-aminobutyric acid secretion(GO:0014051) regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.0 | 0.3 | GO:0090398 | cellular senescence(GO:0090398) |
0.0 | 0.1 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.0 | 0.0 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.0 | 0.0 | GO:1904478 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal absorption(GO:1904478) regulation of intestinal lipid absorption(GO:1904729) |
0.0 | 0.1 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.1 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
0.0 | 0.0 | GO:0060913 | cardiac cell fate determination(GO:0060913) |
0.0 | 0.0 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.0 | 0.1 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.1 | GO:0090102 | cochlea development(GO:0090102) |
0.0 | 0.1 | GO:0009130 | UMP biosynthetic process(GO:0006222) pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.0 | 0.1 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.0 | 0.0 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.2 | GO:0051307 | resolution of meiotic recombination intermediates(GO:0000712) meiotic chromosome separation(GO:0051307) |
0.0 | 0.1 | GO:0072010 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.0 | 0.1 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) positive regulation of triglyceride catabolic process(GO:0010898) |
0.0 | 0.1 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 0.1 | GO:0050951 | sensory perception of temperature stimulus(GO:0050951) |
0.0 | 0.1 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.0 | 0.3 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.1 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.0 | 0.2 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.0 | 0.1 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.0 | 0.1 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.0 | 0.0 | GO:0043129 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.0 | 0.1 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.1 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.1 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.2 | GO:0045008 | depyrimidination(GO:0045008) |
0.0 | 0.1 | GO:0044253 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.0 | 0.0 | GO:0048679 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.0 | 0.1 | GO:0051818 | disruption of cells of other organism involved in symbiotic interaction(GO:0051818) killing of cells in other organism involved in symbiotic interaction(GO:0051883) |
0.0 | 0.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
0.0 | 0.4 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.0 | 0.1 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.0 | 0.1 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.0 | 0.3 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.0 | 0.0 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.0 | 0.2 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.0 | 0.5 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.0 | GO:0060602 | branch elongation of an epithelium(GO:0060602) |
0.0 | 0.1 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.0 | 0.1 | GO:0070091 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
0.0 | 0.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.4 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 0.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.0 | 1.0 | GO:0051291 | protein heterooligomerization(GO:0051291) |
0.0 | 0.1 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.0 | 0.0 | GO:0090026 | regulation of monocyte chemotaxis(GO:0090025) positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.2 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.0 | 0.5 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.1 | GO:1904358 | positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.0 | 0.1 | GO:0019985 | translesion synthesis(GO:0019985) |
0.0 | 0.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.1 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.0 | 0.0 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.0 | 0.0 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.0 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 1.0 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.1 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.0 | 0.2 | GO:0042436 | tryptophan catabolic process(GO:0006569) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.0 | 0.0 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.1 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 0.1 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.0 | 1.7 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.2 | GO:0009261 | ribonucleotide catabolic process(GO:0009261) |
0.0 | 0.2 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.0 | 0.0 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.0 | 0.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.0 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.0 | 0.0 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.0 | 0.0 | GO:1903077 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.0 | 0.1 | GO:0030238 | male sex determination(GO:0030238) |
0.0 | 0.1 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.1 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.0 | 0.0 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.0 | 0.2 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.0 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.0 | 0.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.0 | 0.1 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.0 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.3 | GO:0030177 | positive regulation of Wnt signaling pathway(GO:0030177) |
0.0 | 0.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.0 | GO:0036315 | cellular response to sterol(GO:0036315) cellular response to cholesterol(GO:0071397) |
0.0 | 0.1 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) |
0.0 | 0.0 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 0.1 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.0 | GO:0051552 | flavone metabolic process(GO:0051552) |
0.0 | 0.1 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.0 | 0.0 | GO:1903008 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) organelle disassembly(GO:1903008) |
0.0 | 0.1 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.1 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
0.0 | 0.0 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.0 | 0.1 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.0 | 0.1 | GO:0007549 | dosage compensation(GO:0007549) |
0.0 | 0.1 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
0.0 | 0.0 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.0 | 0.0 | GO:0006949 | syncytium formation(GO:0006949) |
0.0 | 0.1 | GO:0033280 | response to vitamin D(GO:0033280) |
0.0 | 0.0 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.0 | 0.0 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.0 | 0.0 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 0.7 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.5 | 2.0 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.4 | 1.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.4 | 1.2 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.4 | 2.3 | GO:0001527 | microfibril(GO:0001527) |
0.4 | 1.1 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.4 | 0.4 | GO:0060199 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.4 | 2.5 | GO:0005915 | zonula adherens(GO:0005915) |
0.3 | 1.0 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.3 | 1.8 | GO:0031512 | motile primary cilium(GO:0031512) |
0.3 | 0.3 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.3 | 2.2 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
0.3 | 1.1 | GO:0033268 | node of Ranvier(GO:0033268) |
0.3 | 0.8 | GO:0032449 | CBM complex(GO:0032449) |
0.3 | 0.8 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 1.2 | GO:0070083 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.2 | 0.7 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.2 | 0.7 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.2 | 1.2 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.2 | 1.8 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 0.5 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.2 | 0.7 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.2 | 0.6 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.2 | 0.6 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.2 | 0.6 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 0.6 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.2 | 0.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 0.8 | GO:0036126 | outer dense fiber(GO:0001520) sperm flagellum(GO:0036126) |
0.2 | 1.0 | GO:0042599 | lamellar body(GO:0042599) |
0.2 | 1.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 1.0 | GO:0016342 | catenin complex(GO:0016342) |
0.2 | 0.7 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.2 | 1.2 | GO:0002102 | podosome(GO:0002102) |
0.2 | 0.8 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.2 | 16.8 | GO:0005925 | focal adhesion(GO:0005925) |
0.2 | 0.8 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.9 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.4 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.4 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 1.4 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 1.1 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 0.4 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.2 | GO:0002141 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.1 | 1.0 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 1.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 2.0 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 1.0 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 0.4 | GO:0001740 | Barr body(GO:0001740) |
0.1 | 0.5 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.4 | GO:0031211 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 25.1 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 0.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.3 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 0.6 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 0.5 | GO:0043034 | costamere(GO:0043034) |
0.1 | 0.2 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.6 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.1 | 0.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.9 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 0.5 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.1 | 0.6 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 1.1 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.2 | GO:0033646 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 0.3 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.2 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.2 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.5 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 1.9 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 0.3 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.2 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 1.0 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.5 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.1 | 0.8 | GO:0034706 | sodium channel complex(GO:0034706) |
0.1 | 2.4 | GO:0044309 | neuron spine(GO:0044309) |
0.1 | 2.7 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 0.3 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.1 | 0.2 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 0.6 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 1.7 | GO:0031983 | vesicle lumen(GO:0031983) |
0.0 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 2.0 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.4 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.7 | GO:0032432 | actin filament bundle(GO:0032432) |
0.0 | 0.6 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.0 | 1.2 | GO:0030017 | sarcomere(GO:0030017) |
0.0 | 0.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.2 | GO:0000125 | PCAF complex(GO:0000125) |
0.0 | 0.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.9 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.1 | GO:0005652 | nuclear lamina(GO:0005652) |
0.0 | 0.1 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 1.6 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.0 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.0 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.0 | 0.1 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.4 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.5 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 1.4 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) respiratory chain complex IV(GO:0045277) |
0.0 | 0.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.1 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.1 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 2.5 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.1 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 0.3 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.1 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.0 | 0.1 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.1 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.0 | 0.3 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.1 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 0.0 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.0 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.0 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 1.1 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.0 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.5 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.0 | GO:0070822 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
0.0 | 0.1 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.0 | 0.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.0 | 0.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.5 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.8 | 3.2 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.7 | 0.7 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.6 | 1.7 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.6 | 1.7 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.5 | 2.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.5 | 1.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.5 | 1.5 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.5 | 3.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.5 | 1.5 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.4 | 0.4 | GO:0043559 | insulin binding(GO:0043559) |
0.4 | 1.8 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.4 | 1.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.4 | 1.3 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.4 | 1.3 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.4 | 1.6 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.4 | 0.8 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.4 | 2.7 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.4 | 2.2 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.4 | 3.3 | GO:0017166 | vinculin binding(GO:0017166) |
0.4 | 0.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.4 | 1.1 | GO:0097493 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.4 | 1.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.4 | 1.4 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.4 | 3.5 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.3 | 1.0 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.3 | 0.7 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.3 | 1.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.3 | 1.3 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.3 | 1.0 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.3 | 1.3 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.3 | 1.2 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.3 | 1.6 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.3 | 0.9 | GO:0004103 | choline kinase activity(GO:0004103) |
0.3 | 1.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.3 | 2.9 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.3 | 0.9 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.3 | 0.9 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.3 | 2.0 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.3 | 0.3 | GO:0070052 | collagen V binding(GO:0070052) |
0.3 | 1.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.3 | 0.8 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.3 | 0.3 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.3 | 0.8 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.3 | 0.8 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.2 | 1.7 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.2 | 0.7 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.2 | 1.0 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 1.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.2 | 1.4 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.2 | 0.7 | GO:0046980 | tapasin binding(GO:0046980) |
0.2 | 0.5 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 0.9 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.2 | 0.7 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.2 | 0.4 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.2 | 0.6 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.2 | 0.9 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.2 | 0.6 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.2 | 1.2 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.2 | 0.6 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.2 | 1.2 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.2 | 0.8 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.2 | 3.7 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.2 | 0.6 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.2 | 0.6 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.2 | 0.6 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.2 | 1.9 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.2 | 0.9 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.2 | 1.5 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.2 | 0.5 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.2 | 0.4 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.2 | 0.4 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 0.9 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.2 | 1.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.2 | 0.5 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 0.8 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.2 | 1.7 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.2 | 1.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 1.0 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.2 | 1.8 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.2 | 1.4 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.2 | 0.5 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.2 | 1.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.2 | 3.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.2 | 0.3 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.1 | 0.7 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.1 | 1.3 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.9 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.6 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.7 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 0.6 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.4 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.9 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.1 | 0.9 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 1.0 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 0.8 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.8 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.4 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 1.2 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.7 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.1 | 0.4 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 0.1 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) |
0.1 | 0.1 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.9 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.4 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.1 | 1.4 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.8 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 1.0 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 1.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 3.0 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.4 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.1 | 0.5 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.4 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.1 | 0.2 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 0.7 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 1.2 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.1 | 0.5 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 8.4 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 1.6 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 1.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.7 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.1 | 0.3 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.1 | 0.4 | GO:0004083 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) |
0.1 | 0.3 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 1.0 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.2 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.1 | 0.7 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.3 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.3 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.3 | GO:0035514 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.1 | 0.3 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.3 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.4 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.3 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.1 | 0.7 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 0.3 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.1 | 0.3 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.1 | 1.7 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 0.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.6 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 1.9 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.3 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.1 | 3.9 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.4 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 0.4 | GO:0005497 | androgen binding(GO:0005497) |
0.1 | 1.9 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 1.0 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 0.9 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 0.2 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.1 | 0.4 | GO:0098988 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.1 | 3.4 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.1 | 0.2 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.2 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.1 | 1.1 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
0.1 | 0.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.2 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.5 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 1.9 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.2 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.1 | 0.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.5 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.1 | 1.1 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.4 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 1.0 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 1.0 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 0.1 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.6 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 0.6 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.2 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.3 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.1 | 0.3 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.1 | 0.2 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 0.2 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 1.1 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 0.3 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.3 | GO:0031545 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.6 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.3 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 0.3 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.4 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.7 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.1 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.1 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.3 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.1 | 0.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.2 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 0.2 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 0.2 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.1 | 0.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.5 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.5 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.2 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 1.0 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 0.3 | GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.3 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.0 | 0.2 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.0 | 0.1 | GO:0000987 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
0.0 | 0.4 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 0.2 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.2 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.2 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.4 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.1 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.0 | 0.2 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.0 | 3.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.1 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.0 | 0.2 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.0 | 0.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.4 | GO:0016248 | ion channel inhibitor activity(GO:0008200) channel inhibitor activity(GO:0016248) |
0.0 | 0.2 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.0 | 0.5 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.8 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.0 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.0 | 0.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.3 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.0 | 0.1 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.0 | 0.1 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.0 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.0 | 0.1 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.0 | 0.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.0 | GO:0004340 | glucokinase activity(GO:0004340) |
0.0 | 0.4 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.0 | 0.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.0 | 0.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.1 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.0 | 0.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.4 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.0 | 0.2 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 0.4 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.1 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.6 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.1 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.0 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.4 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.1 | GO:0043398 | HLH domain binding(GO:0043398) |
0.0 | 2.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.0 | 0.1 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.4 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.2 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.0 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 0.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.0 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 1.2 | GO:0005254 | chloride channel activity(GO:0005254) |
0.0 | 0.2 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.0 | 0.2 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.4 | GO:0042562 | hormone binding(GO:0042562) |
0.0 | 0.0 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 0.2 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.1 | GO:0001077 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.0 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.0 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.0 | 0.1 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.2 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
0.0 | 0.0 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.0 | 0.1 | GO:0016847 | 1-aminocyclopropane-1-carboxylate synthase activity(GO:0016847) |
0.0 | 0.9 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.1 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.0 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.0 | 0.1 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.3 | GO:0016684 | peroxidase activity(GO:0004601) oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.0 | 0.2 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.0 | 0.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.0 | GO:0030354 | melanin-concentrating hormone activity(GO:0030354) |
0.0 | 0.0 | GO:0045569 | TRAIL binding(GO:0045569) |
0.0 | 0.0 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.0 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.0 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 1.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.9 | 0.9 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.5 | 0.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.4 | 0.4 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.3 | 3.0 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.3 | 5.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.3 | 0.5 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 0.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.2 | 0.8 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 4.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 6.5 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 5.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 2.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 3.7 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 19.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 1.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 3.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 1.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 14.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 2.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 2.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 1.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 0.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 1.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 2.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.0 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 1.0 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.8 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 1.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 1.1 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.3 | 3.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.3 | 7.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.3 | 4.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.3 | 0.3 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.3 | 0.6 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.3 | 3.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 0.2 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.2 | 2.3 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.2 | 3.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 2.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.2 | 1.6 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.2 | 0.5 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.2 | 2.1 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.1 | 2.2 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 1.5 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 1.8 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 3.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 0.3 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.1 | 3.2 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 0.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 2.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 1.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 1.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 1.0 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 0.7 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.7 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 1.0 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 1.1 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 5.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.0 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 0.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 0.9 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 2.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 0.4 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 0.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 0.5 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 0.7 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.1 | 1.9 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 2.7 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 0.5 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 0.7 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 0.3 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 0.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 0.4 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 1.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 1.9 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.6 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 1.0 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 1.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 1.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 0.5 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 1.9 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 0.7 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 0.6 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 0.1 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.1 | 0.5 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 0.1 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.0 | 0.5 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.4 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 1.0 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 1.1 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.3 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.2 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.0 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.0 | 0.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.8 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 1.2 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.7 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.3 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.0 | 0.0 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.7 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.3 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.2 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.2 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.1 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.2 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.0 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.0 | 0.1 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |